Epidermal growth factor receptor (EGFR) is reportedly overexpressed in most esophageal squamous cell carcinoma (ESCC) patients, but anti-EGFR treatments offer limited survival benefits. The gene discussed is EGFR; the disease is esophageal squamous cell carcinoma.